RT Journal Article
SR Electronic
T1 Role of ulinastatin in steroid-induced pancreatitis
JF BMJ Case Reports
JO BMJ Case Reports
FD BMJ Publishing Group Ltd
SP e260019
DO 10.1136/bcr-2024-260019
VO 17
IS 6
A1 Prithvi, Devarakonda
A1 Kumar, Neeraj
A1 Kumar, Ajeet
A1 Kumar, Abhyuday
YR 2024
UL http://casereports.bmj.com/content/17/6/e260019.abstract
AB Steroid-induced acute pancreatitis is a rare form of pancreatitis that requires intensive care and has a high morbidity and mortality rate as there is no specific treatment. Management of steroid-induced pancreatitis is generally non-specific and supportive. Here, we are presenting a man in his 40s presented with epigastric pain, fever and vomiting. The patient was diagnosed case of rheumatoid arthritis, for which he was receiving regular 5 mg oral prednisolone therapy. Based on history, and clinical, biochemical and radiological imaging a diagnosis of steroid-induced pancreatitis was made, which was successfully managed with the help of ulinastatin and other supportive treatments. A serine protease inhibitor like ulinastatin may be used early in the clinical management of steroid-induced pancreatitis.